Zanubrutinib succeeds in head-to-head with ibrutinib in R/R CLL

Nature Reviews Clinical Oncology, Published online: 21 December 2022; doi:10.1038/s41571-022-00724-zZanubrutinib succeeds in head-to-head with ibrutinib in R/R CLL

https://www.nature.com/articles/s41571-022-00724-z

Source: Nature Reviews Clinical Oncology - December 21, 2022 Category: Cancer & Oncology Authors: David Killock Source Type: research

More News: Cancer & Oncology